New Research by Israeli Scientists Shows Existing Drugs May Curb Bone Metastasis in Breast Cancer Patients

Research from Tel Aviv University reveals potential breakthrough in treatment, utilizing a novel drug combination to reduce bone metastasis and improve survival rates

By Veronica Neifakh/The Media Line

While complications are prevalent in cancer patients, many people aren’t aware of just how prevalent they are. More than 75% of metastatic breast cancer patients suffer from bone metastasis. Tel Aviv University researchers Prof. Neta Erez and Dr. Lea Monteran have developed a novel therapeutic strategy to address this often-life-threatening complication. Their breakthrough uses a combination of available drugs to slow bone metastasis progression and enhance survival rates.

Brought to you by